Craig Hersh is a Respiratory physician.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
75 Francis St
Brigham And Womens Hospital
Boston, MA 021156110
Telephone
617-732-6770Provider last certified this registry record 25 Nov 2025.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year202514 payments$10,284openpaymentsdata.cms.gov ↗
- GENZYME CORPORATIONProgram year20252 payments
- Genentech USA, Inc.Program year20258 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
79%Corticosteroid44.9%Trelegy Ellipta41%Breztri Aerosphere25%Fluticasone Propionate17%Symbicort6%Budesonide-Formoterol Fumarate4%Dulera4%Arnuity Ellipta3%Part D<11 patientsbeta2-Adrenergic Agonist19.3%Albuterol Sulfate Hfa84%Ventolin Hfa16%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
7.8%Corticosteroid3.1%Prednisone100%Part D≥13 patientsH2 blocker2.7%Famotidine100%Part D<11 patients+ 1 more class in this area
Anti-infectives
7.1%Macrolide Antimicrobial7.1%Azithromycin100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
7 NIH research awards on record, funded 2005–2026 per NIH RePORTER. The latest:
- Defining a gene expression signature of airway disease, COPD exacerbations, and response to treatment
Brigham and Women'S Hospital
FY2026$817,130R01HL166231 - Patient oriented research and mentoring in COPD biomarker studies
Brigham and Women'S Hospital
FY2026$131,783K24HL173667 - Defining a gene expression signature of airway disease, COPD exacerbations, and response to treatment
Brigham and Women'S Hospital
FY2025$832,016R01HL166231
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”